Published on
April 7, 2014
- 16:23 GMT
Immunomic Therapeutics Announces Data Analysis of Phase IB Study to Treat Japanese Red Cedar Allergy
ROCKVILLE, MD, UNITED STATES, April 7, 2014 /EINPresswire.com/ -- Hershey, PA & Rockville, MD April 7th, 2014 – Immunomic Therapeutics, Inc., (“ITI”), a Company on the leading edge of transforming vaccines, announced the preliminary results of a Phase …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
